Get startedLog in
    Picture of Medicinova logo

    MNOV — Medicinova News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    All News

    Brief: Medicinova Announces Completion Of Last Patient, Last Visit In The Double-Blind Portion Of The Phase 2B/3 Combat-Als Trial Of Mn-166

    Picture of Medicinova logoMedicinova
    24/09/2026 11:01
    BRIEF-Medicinova Announces Completion Of Last Patient, Last Visit In The Double-Blind Portion Of The Phase 2B/3 Combat-Als Trial Of Mn-166
    Sept 24 (Reuters) - MediciNova Inc MNOV.O:
    • MEDICINOVA ANNOUNCES COMPLETION OF LAST PATIENT, LAST VISIT IN THE DOUBLE-BLIND PORTION OF THE PHASE 2B/3 COMBAT-ALS TRIAL OF MN-166 (IBUDILAST)
    • MEDICINOVA - TOPLINE RESULTS FROM DOUBLE-BLIND PORTION EXPECTED BY END OF 2026
    Source text: ID:nGNX1whW8
    Further company coverage: MNOV.O

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Medicinova

    See all news